Advertisement

Latest Articles in pharma

‘OTC Allows Us To Keep In Touch With What Indian Consumers Want’

Nandini Piramal, Executive Director, Piramal Enterprises Ltd. leads from the front

Read More

Aurobindo Pharma Eyes US Plant Amid Donald Trump Push On Jobs

Drugmaker Aurobindo Pharma said on Friday it was looking to set up a manufacturing facility for injectable products in the United States, days after President Donald Trump called on pharmaceutical companies to make more drugs locally

Read More

Trump Presidency Impact | A Sickly Outlook

Trump’s interventionist approach can negatively impact the Indian pharma industry, which is heavily dependent on the US market

Read More

Budget 2017 | Amendment In D&C Act To Disrupt Pharma Marketing

The Union Budget-2017 proposal to drastically amend the Drugs and Cosmetics Act to enable availability and affordability of cheaper generic drugs to patients is expected to have key impacts on the local drug industry

Read More

Pharma Industry Wants Budget To Offer Tax Clarity

The pharmaceutical industry has asked the government to bring in more clarity in terms of tax structure and provide incentives on research and development as part of its budget wish-list

Read More

Collaboration Can Lead Us To Better Discovery

Drug discovery has changed. The model of big pharma retaining all the knowledge within has become obsolete

Read More

Sun Pharma Buys Novartis’ Anti-cancer Brand Odomzo For $175 Million

Reason for selling this new anti-cancer drug by Novartis, which consolidated its global oncology business by acquiring the entire cancer drug portfolio of GlaxoSmithKline (GSK) in a $16 billion global deal in March 2015, is not disclosed

Read More

Lupin, Eli Lilly Expand Partnership In India

Lupin will market and sell Eglucent through its own specialty field force while Lilly will be responsible for manufacturing and import

Read More

‘Qualiminds Hopes To Improve The Indian Drug Industry’s Image’

K. Anand, CEO and managing director, Qualiminds, tells BW Businessworld that the pharmaceutical industry’s attitude to compliance with regulatory norms has to change

Read More

Dr Reddy's Profit Misses View As Emerging Markets Sales Fall

Dr Reddy's Laboratories Ltd, India's second-largest drugmaker, reported a quarterly profit that was below analysts' estimates due to a drop in sales, mainly in emerging markets

Read More

Sun Pharma Completes Rs 675-crore Share Buyback

As per Sebi guidelines, 15 per cent of the buyback offer is reserved for shareholders holding shares having a market value of not more than Rs 2,00,000 as on the record date

Read More

Drug Firms Facing Challenging Times Due To Price Control: Cipla

Drug companies are facing a tough environment due to the government bringing more products under the price control policy as also tightening of registration procedure that has impacted time to market newer products

Read More

Zydus Cadila Ties Up With Takeda To Develop Chikungunya Vaccine

Cadila Healthcare says the terms of the agreement are not disclosed, but it is expected that this partnership will boost access to medicines in the future

Read More